SeaStar Medical Holding Statistics
Total Valuation
ICU has a market cap or net worth of $14.82 million. The enterprise value is $3.36 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU has 3.99 million shares outstanding. The number of shares has increased by 453.77% in one year.
| Current Share Class | 3.99M |
| Shares Outstanding | 3.99M |
| Shares Change (YoY) | +453.77% |
| Shares Change (QoQ) | +37.22% |
| Owned by Insiders (%) | 1.06% |
| Owned by Institutions (%) | 2.52% |
| Float | 3.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.01 |
| Forward PS | 7.85 |
| PB Ratio | 1.37 |
| P/TBV Ratio | 1.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.63, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.63 |
| Quick Ratio | 3.26 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -392.74 |
Financial Efficiency
Return on equity (ROE) is -295.15% and return on invested capital (ROIC) is -163.08%.
| Return on Equity (ROE) | -295.15% |
| Return on Assets (ROA) | -80.88% |
| Return on Invested Capital (ROIC) | -163.08% |
| Return on Capital Employed (ROCE) | -116.89% |
| Weighted Average Cost of Capital (WACC) | -2.05% |
| Revenue Per Employee | $72,588 |
| Profits Per Employee | -$714,706 |
| Employee Count | 17 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ICU has paid $3,000 in taxes.
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.32% in the last 52 weeks. The beta is -1.19, so ICU's price volatility has been lower than the market average.
| Beta (5Y) | -1.19 |
| 52-Week Price Change | -70.32% |
| 50-Day Moving Average | 2.75 |
| 200-Day Moving Average | 4.88 |
| Relative Strength Index (RSI) | 58.92 |
| Average Volume (20 Days) | 265,326 |
Short Selling Information
The latest short interest is 167,946, so 4.21% of the outstanding shares have been sold short.
| Short Interest | 167,946 |
| Short Previous Month | 233,272 |
| Short % of Shares Out | 4.21% |
| Short % of Float | 4.25% |
| Short Ratio (days to cover) | 3.20 |
Income Statement
In the last 12 months, ICU had revenue of $1.23 million and -$12.15 million in losses. Loss per share was -$5.86.
| Revenue | 1.23M |
| Gross Profit | 1.18M |
| Operating Income | -12.18M |
| Pretax Income | -12.15M |
| Net Income | -12.15M |
| EBITDA | n/a |
| EBIT | -12.18M |
| Loss Per Share | -$5.86 |
Full Income StatementBalance Sheet
The company has $11.98 million in cash and $525,000 in debt, with a net cash position of $11.46 million or $2.87 per share.
| Cash & Cash Equivalents | 11.98M |
| Total Debt | 525,000 |
| Net Cash | 11.46M |
| Net Cash Per Share | $2.87 |
| Equity (Book Value) | 10.42M |
| Book Value Per Share | 2.71 |
| Working Capital | 9.84M |
Full Balance SheetCash Flow
| Operating Cash Flow | -13.60M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | -67,000 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | 95.71% |
| Operating Margin | -986.63% |
| Pretax Margin | -984.36% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ICU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -453.77% |
| Shareholder Yield | -453.77% |
| Earnings Yield | -82.00% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 5, 2026. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 5, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ICU has an Altman Z-Score of -14.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.55 |
| Piotroski F-Score | 2 |
